Cidara Therapeutics (CDTX) filed a registration statement Monday with the US Securities and Exchange Commission covering the potential resale of up to 7.04 million common shares by certain stockholders from time to time.
The company said that 3.89 million of the shares are issued and outstanding, while the remaining are issuable upon the exercise of prefunded warrants.
Cidara isn't selling any shares under the statement and won't receive any proceeds from the sale by the investors.
The company's shares fell 1.7% in after-hours activity.
Price: 23.01, Change: -0.39, Percent Change: -1.67
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。